Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.65 |
| ▸ | IDE | P14735 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 8/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 8/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | MMP2 | P08253 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38664990 | 1.00 | MYC (0.65) | MYCIDEMAPTALDH1A1GAA | |
| SCHEMBL3412051 | 1.00 | MYC (0.65) | MYCIDEMAPTALDH1A1GAA | |
| SCHEMBL4552496 | 0.83 | MAPT (0.49) | MYCIDEMAPTALDH1A1GAA | |
| SCHEMBL68504 | 0.83 | IDE (0.71) | MYCIDEMAPTALDH1A1GAA | |
| SCHEMBL68503 | 0.83 | IDE (0.71) | MYCIDEMAPTALDH1A1GAA | |
| SCHEMBL38663450 | 0.83 | MYC (0.57) | MYCIDEMAPTALDH1A1GAA | |
| SCHEMBL17784943 | 0.82 | MYC (0.53) | MYCIDEMAPTALDH1A1GAA | |
| SCHEMBL8722208 | 0.81 | MAPT (0.48) | MYCMAPTALDH1A1GAATP53 | |
| SCHEMBL15240 | 0.79 | ALDH1A1 (0.72) | MYCMAPTALDH1A1GAATP53 | |
| SCHEMBL6536926 | 0.79 | KMT2A (0.61) | MYCIDEMAPTALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1504100-A1 | NEW FLUORESCENCE BASED BIOSENSOR | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2005-02-09 | — | — | EP | claimed |
| US-6677159-B1 | INSTANTANEOUS AND REVERSIBLE COLORIMETRIC MONITORING | SOUTHWEST RESEARCH INSTITUTE | 2004-01-13 | — | — | US | claimed |
| WO-2003095648-A1 | NEW FLUORESCENCE BASED BIOSENSOR | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2003-11-20 | — | — | WO | claimed |
| US-20030087451-A1 | Acid test kit | MAINSTREAM ENGINEERING CORP. | 2003-05-08 | — | — | US | claimed |
| WO-2001018017-A9 | METHODS FOR DETECTING AND ENUMERATING CAMPYLOBACTER JEJUNI IN ENVIRONMENTAL SAMPLES AND FOR IDENTIFYING ANTIBIOTIC-RESISTANT STRAINS | UNIV MICHIGAN STATE (US) | 2002-09-26 | — | — | WO | claimed |
| WO-2001018017-A1 | METHODS FOR DETECTING AND ENUMERATING CAMPYLOBACTER JEJUNI IN ENVIRONMENTAL SAMPLES AND FOR IDENTIFYING ANTIBIOTIC-RESISTANT STRAINS | MICHIGAN STATE UNIVERSITY (US) | 2001-03-15 | — | — | WO | claimed |
| US-5846836-A | Reversible detector for gaseous carbon dioxide | SOUTHWEST RESEARCH INSTITUTE (US) | 1998-12-08 | — | — | US | claimed |
| US-5094545-A | Solid solution with nucleating agent and indicator dye | PYMA CORPORATION (US) | 1992-03-10 | — | — | US | claimed |
| US-12545636-B2 | Acyclic lipids and methods of use thereof | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250313525-A1 | CONSTRAINED LIPIDS AND METHODS OF USE THEREOF | RENAGADE THERAPEUTICS MAN INC (US) | 2025-10-09 | — | — | US | disclosed |
| US-20250154102-A1 | CYCLIC LIPIDS AND METHODS OF USE THEREOF | RENAGADE THERAPEUTICS MAN INC (US) | 2025-05-15 | — | — | US | disclosed |
| US-12215068-B2 | Constrained lipids and methods of use thereof | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2025-02-04 | — | — | US | disclosed |
| EP-4452928-A1 | CONSTRAINED LIPIDS AND METHODS OF USE THEREOF | Renagade Therapeutics Management Inc. (US) | 2024-10-30 | — | — | EP | disclosed |
| EP-4402121-A1 | ACYCLIC LIPIDS AND METHODS OF USE THEREOF | Renagade Therapeutics Management Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-0246814-A2 | Process for producing toner by suspension polymerization method | CANON KABUSHIKI KAISHA (JP) | 1987-11-25 | — | — | EP | disclosed |
| US-4702988-A | FORMING POLYMERIZABLE MONOMER DISPERSION CONTAINING COLORANT, PRESSURIZING, EJECTING TO FORM PARTICLES, POLYMERIZING | CANON KABUSHIKI KAISHA (JP) | 1987-10-27 | — | — | US | disclosed |
| US-4626489-A | Process for producing toner for development of electrostatic images by stepwise suspension polymerization | CANON KABUSHIKI KAISHA (JP) | 1986-12-02 | — | — | US | disclosed |
| US-4609607-A | Magnetic toner and process for producing the same | CANON KABUSHIKI KAISHA (JP) | 1986-09-02 | — | — | US | disclosed |
| US-4601968-A | Process for producing toner for development of electrostatic images by stepwise suspension polymerizations | CANON KABUSHIKI KAISHA (JP) | 1986-07-22 | — | — | US | disclosed |
| US-4448871-A | ADDITION POLYMERIZATION USING STABILIZER OF ALUMINUM, FERRIC, TITANIUM OR THORIUM HYDROXIDE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313525-A1 | CONSTRAINED LIPIDS AND METHODS OF USE THEREOF | SGMS1, SGMS2, LNPEP | MYC 2760/4885IDE 1703/4885MAPT 3403/4885 |
| US-12545636-B2 | Acyclic lipids and methods of use thereof | PLTP, LNPEP, PCTP | MYC 4413/4885IDE 936/4885MAPT 2004/4885 |
| US-12215068-B2 | Constrained lipids and methods of use thereof | SGMS1, SGMS2, LNPEP | MYC 2760/4885IDE 1703/4885MAPT 3403/4885 |
| US-20250154102-A1 | CYCLIC LIPIDS AND METHODS OF USE THEREOF | SGMS1, SGMS2, LNPEP | MYC 3067/4885IDE 1780/4885MAPT 4102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.